Key points
- The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines to control disease in the United States.
- These recommendations become official CDC policy once adopted by CDC's Director.
- Learn about current and historical ACIP recommendations for Yellow Fever vaccine.
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Yellow Fever vaccine recommendations
- MMWR, June 19, 2015, Vol 64, #23. Yellow Fever Vaccine Booster Doses
- MMWR, July 30, 2010, Vol 59, #RR-07 Yellow Fever Vaccine
- MMWR, January 4, 2008, Vol 56, #51 Notice to Readers: Requirements for Use of a New International Certificate of Vaccination or Prophylaxis for Yellow Fever Vaccine
- See also: CDC's Traveler's Yellow Book on Yellow Fever
ARCHIVED historical Yellow Fever immunization publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, February 12, 2010, Vol 59, #5
Transmission of Yellow Fever Vaccine Virus Through Breast-Feeding — Brazil, 2009
Print version - MMWR, November 8, 2002, Vol 51, #RR-17
Yellow Fever Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002
Print version - MMWR, November 8, 2002, Vol 51, #RR-17 (see page 11)
Notice to Readers: Appendix Waiver Letters from Physicians
Print version - MMWR, November 8, 2002, Vol 51, #44
Adverse Events Associated with 17D-Derived Yellow Fever Vaccination – United States, 2001-2002
Print version - MMWR, August 3, 2001, 50, Vol 50, #30
Notice to Readers: Fever, Jaundice, and Multiple Organ System Failure Associated With 17D-Derived Yellow Fever Vaccination, 1996-2001
Print version